目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T62743 | Others | ||
AChE-IN-10 (Compound 24r) 是一种 AChE 的有效抑制剂,其 IC50 值为 2.4 nM。AChE-IN-10 在 AChE 存在下能够降低淀粉样蛋白的聚集。AChE-IN-10 对 AChE 表现出有效抑制作用,可以降低 S396 残基的 tau 磷酸化,挽救神经元形态和增加细胞活力,进而提供神经保护作用。 | |||
T61969 | AChR AChE | ||
AChE/BChE-IN-10 (Compound 7b) 是有效的、血脑屏障渗透性的 AChE 和 BChE 双重抑制剂,IC50 值分别为 0.176 和 0.47 μM。AChE/BChE-IN-10 可以抑制 Aβ 的聚集。 | |||
T62541 | Others | ||
AChE-IN-22 (compound 10q) 是一种乙酰胆碱酯酶 (AChE) 的选择性抑制剂,能够作用于 AChE (IC50: 0.88 μM) 和 BuChE (IC50: 10 μM)。AChE-IN-22 能够同时与 AChE 的 CAS (catalytic active site) 和 PAS (peripheral anionic site) 位点结合,可用于研究阿尔茨海默病。 | |||
T85555 | |||
AChE-IN-63 是一种 hAChE、hBChE 和 hBACE-1 的抑制剂 (IC50 = 0.103 μM (hAChE),10 μM (hBChE) 和 1.342 μM (hBACE-1)),可抑制 Aβ 聚集,防止 Aβ1-42 的形成和沉积。AChE-IN-63 能有效穿透血脑屏障,具有口服有效性,主要用于阿尔茨海默病的研究。 | |||
T78860 | Monoamine Oxidase | ||
MAO-B-IN-24(化合物11h)为针对MAO-B的选择性、可逆性竞争抑制剂,抑制常数(IC50)为1.60 μM。该化合物同样对MAO-A表现出一定抑制效果(22.42 μM),并在10 μM的浓度时分别降低了AChE和BChE的活性至54.58%及88.43%。 | |||
TN4286 | NOS NF-κB ROS AChR | ||
Isodunnianol exhibits anti-AChE activity with an IC50 value of 13.0 uM; it also exhibits neurite outgrowth-promoting activity at the concentration ranging from 0.1 to 10 uM in the primary cultured rat cortical neurons. Isodunnianol, dunnianol, and Macrant | |||
T35975 | Others | ||
6,9-Dichloro-1,2,3,4-tetrahydroacridine is a synthetic intermediate in the synthesis of tacrine-based acetylcholinesterase (AChE) inhibitors.1It is also an intermediate in the synthesis of multifunctional tacrine hybrids that possess radical scavenging, amyloid-β aggregation inhibitory, and/or β-secretase 1 (BACE1) inhibitory activities in addition to their activity as AChE inhibitors.2,3 1.Recanatini, M., Cavalli, A., Belluti, F., et al.SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: Synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analoguesJ. Med. Chem.43(10)2007-2018(2000) 2.Digiacomo, M., Chen, Z., Wang, S., et al.Synthesis and pharmacological evaluation of multifunctional tacrine derivatives against several disease pathways of ADBioorg. Med. Chem. Lett.25(4)807-810(2015) 3.Li, S.Y., Jiang, N., Xie, S.S., et al.Design, synthesis and evaluation of novel tacrine-rhein hybrids as multifunctional agents for the treatment of Alzheimer's diseaseOrg. Biomol. Chem.12(5)801-814(2014) |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPY-01751 | DR3/TNFRSF25 Protein, Human, Recombinant (hFc) | Human | HEK293 Cells | ||
DR3/TNFRSF25 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 45.9 kDa and the accession number is Q93038-10.
|
|||||
TMPY-00961 | ADAM15 Protein, Human, Recombinant (His) | Human | HEK293 Cells | ||
ADAM15 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 54 kDa and the accession number is Q13444-10.
|
|||||
TMPY-02300 | BIN1 Protein, Human, Recombinant (His) | Human | E. coli | ||
Amphiphysin 2, also named bridging integrator-1 (BIN1) or SH3P9, Amphiphysin2/BIN1 is a crescent-shaped N-BAR protein playing a key role in forming deeply invaginated tubes in muscle T-tubules, has been recently implicated in rare and common diseases affecting different tissues and physiological functions. BIN1 downregulation is linked to cancer progression and also correlates with ventricular cardiomyopathy and arrhythmia preceding heart failure. Increased BIN1 expression is linked to increased susceptibility for late-onset Alzheimer's disease. In addition, altered splicing may account for the muscle component of myotonic dystrophies, while recessive germinal mutations cause centronuclear myopathy. Bridging integrator 1 (BIN1) as a late-onset Alzheimer's disease (AD) susceptibility gene. There are at least 15 different known isoforms of BIN1, with many being expressed in the brain including the longest isoform (iso1), which is brain-specific and localizes to axon initial segments and nodes of Ranvier. The bridging integrator 1 (BIN1) tumor suppressor encodes multiple alternatively spliced isoforms implicated in DNA repair, cell-cycle control, apoptosis and membrane dynamics.
|
|||||
TMPY-05760 | DR3/TNFRSF25 Protein, Human, Recombinant (hFc), Biotinylated | Human | HEK293 Cells | ||
DR3/TNFRSF25 Protein, Human, Recombinant (hFc), Biotinylated is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 45.9 kDa and the accession number is Q93038-10.
|